Status:
COMPLETED
Communication Book in Pragmatic Communication in Vascular Aphasics
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Aphasia
Communication
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to evaluate, in communication tasks, the pragmatic effectiveness of the communication book in the general conditions of use and its maintenance in the implementation of the compensator...
Detailed Description
Data from the literature have demonstrated the effectiveness of speech therapy in aphasic vascular. In the face of sequelae, particularly in the most serious aphasia, a palliative approach aims to inc...
Eligibility Criteria
Inclusion
- Informed consent after information. Information is also given to the person of trust when it exists.
- aphasic subjects admitted to hospital or seen in consultation following a 1st ischemic or hemorrhagic symptomatic vascular accident constituted
- during the first year of onset of aphasia
- adults over 18 years old
- French
- phasic disorder of severe severity expression (overall severity score between 0 and 2 at the diagnostic battery for the assessment of aphasia scale)
- residual ability to understand clinical assessments and informed consent; information about the objectives and the procedure of the research will also be given to the patient's designated confidant
- motor capacity for comfortable sitting and transfers with help
- affiliation to health insurance
- no deficits in visual perceptual tests (researched using the visual decision of objects and Montreal protocol for the evaluation of visual gnosis), which allows the use of the communication book,
Exclusion
- refusal or impossibility of consent
- disturbance of vigilance
- insane state
- psychiatric history requiring hospitalization in a specialized environment
- perceptual disturbance, visual agnosia not allowing the use of the image support
- pregnancy or breastfeeding
- administration after the occurrence of stroke of a product for which an effect on the recovery of aphasia has been reported: piracetam, bromocriptine, donepezil, dextroamphetamine (if treatment with these products has been performed, inclusion is possible after a weaning period of 15 days)
- simultaneous inclusion in another therapeutic protocol of language disorders
Key Trial Info
Start Date :
February 17 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 10 2012
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04070625
Start Date
February 17 2009
End Date
February 10 2012
Last Update
August 28 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.